{
    "name": "mafenide",
    "comment": "Rx",
    "other_names": [
        "Sulfamylon"
    ],
    "classes": [
        "Antibacterials",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/sulfamylon-mafenide-343465",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Not known whether distributed into breast milk, discontinue drug or do not nurse"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Not known whether distributed into breast milk, discontinue drug or do not nurse"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to mafenide or any component of the formulation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Hypersensitivity",
                "Use extreme caution in patients with sulfonamide allergy",
                "E. coli & Proteus spp. appear to be less sensitive",
                "Prolonged use may result in fungal or bacterial superinfection including C. difficile-associated diarrhea and pseudomembranous colitis",
                "Pregnancy/women of childbearing potential-not recommended in women of childbearing potential unless burned area >20% BSA or benefits justify possible risks to the fetus",
                "G-6-PD deficiency; may result in hemolytic anemia"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "allogeneic cultured keratinocytes and fibroblasts",
            "description": {
                "common": "mafenide decreases effects of allogeneic cultured keratinocytes and fibroblasts by Other (see comment). Avoid or Use Alternate Drug. \nComment: Mafenide acetate, a topical antimicrobial, reduces keratinocyte viability and disrupt integrity of tissue-engineered human skin substitutes composed of keratinocytes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dichlorphenamide",
            "description": {
                "common": "dichlorphenamide, mafenide.\nEither increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Both drugs can cause metabolic acidosis."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Application site reactions",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "Facial edema",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Excoriation",
            "percent": null
        },
        {
            "name": "Pain",
            "percent": null
        },
        {
            "name": "Blisters",
            "percent": null
        },
        {
            "name": "Burning sensation",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Bone marrow suppression",
            "percent": null
        },
        {
            "name": "Anemia",
            "percent": null
        },
        {
            "name": "Eosinophilia",
            "percent": null
        },
        {
            "name": "Porphyria",
            "percent": null
        },
        {
            "name": "Hyperventilation",
            "percent": null
        },
        {
            "name": "Hemolytic anemia",
            "percent": null
        },
        {
            "name": "Allergic reactions",
            "percent": null
        },
        {
            "name": "Systemic acidosis with tachypnea",
            "percent": null
        }
    ]
}